Clinical trial
Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With…
NCT00023153 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00023153 |
|---|---|
| Title | Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection |
| Official title | Studies of the Addition of Adefovir Dipivoxil to Lamivudine for the Treatment of Chronic Hepatitis B: A Randomized, Double-Blind, Placebo Controlled Study in HIV-Infected Patients and an Open-Label Study in HIV-Negative Subjects |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | Adefovir Dipivoxil |
| Enrollment | 100 |
| Start date | Aug 1, 2001 |
| Completion | Oct 1, 2004 |
| First posted | Aug 27, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: